Research Paper Volume 15, Issue 16 pp 8113—8136
Comprehensive characterization of pyroptosis phenotypes with distinct tumor immune profiles in gastric cancer to aid immunotherapy
Figure 9. Validation of the predictive efficacy of the pyroptosis score for immunotherapeutic responses in two anti-PD-1 cohorts. (A) The fraction of patients with clinical response to anti-PD-1 therapy in high and low pyroptosis score groups from the GSE78220 cohort. (B) Kaplan-Meier curves for patients with high and low pyroptosis scores in the GSE78220 cohort (log-rank test). (C) The fractions of patients who presented therapeutic responses to anti-PD-1 therapy in high and low pyroptosis score groups from the Liu cohort. (D) Kaplan-Meier curves of patients with high and low pyroptosis scores in the Liu cohort (log-rank test). Abbreviations: CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease.